| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/14/1999 | US5952467 Protein which interacts with protein kinase in mitosis; treatment of cardiovascular disorders, septic shock, psoriasis, respiratory diseases, acquired immune deficiency syndrome; antiischemic/antiproliferative agents |
| 09/14/1999 | US5952466 Reductive alkylation of glycopeptide antibiotics |
| 09/14/1999 | US5952465 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 09/14/1999 | US5952464 Oligopeptide with selective neurotensin receptor affinity labelled with metal isotope or radioactive halogen isotope; for diagnostic imaging and anticarcinogenic agents |
| 09/14/1999 | US5952461 Process for preparing human proinsulin |
| 09/14/1999 | US5952371 Triterpene derivatives with immunosuppressant activity |
| 09/14/1999 | US5952327 Neutral endopeptidase inhibitors; treatment of cardiovascular disorders |
| 09/14/1999 | US5952311 Photosensitizing chemical means for killing tumor cells, wherein tumoricidal activity is activated by absorbing light or energy within a specific wavelength range, and energy donating chemical means for activating photosensitizer |
| 09/14/1999 | US5952310 Bactericides |
| 09/14/1999 | US5952307 Antiinflammatory agents, anticoagulants, antitumor agents |
| 09/14/1999 | US5952305 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
| 09/14/1999 | US5952304 Platelet-derived growth factor analogues |
| 09/14/1999 | US5952303 A freeze-dryed artificial pulmonary surfactant comprising kl4 polypeptide and di- and monopalmitoylphosphatidylcholine; storage stability; nonhydrolyzing; reduced viscosity; homogeneity |
| 09/14/1999 | US5952302 Human therapeutic uses of BPI protein products |
| 09/14/1999 | US5952301 A synergistic mixture of the peptide hormones, glucagon-like peptide-2 (glp-2) and insulin-like growth factor (igf-1,2) or growth hormone to promote the cell growth in the large and small intestines; nutritional, gastrointestinal disorders |
| 09/14/1999 | US5952300 Antifungal compositions |
| 09/14/1999 | US5952299 Cyclic peptide nuclei and derivatives thereof |
| 09/14/1999 | US5952297 Monomeric insulin analog formulations |
| 09/14/1999 | US5952296 Method of using relaxin as therapeutic or preventing agent |
| 09/14/1999 | US5952295 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| 09/14/1999 | US5952294 Peptidyl prodrugs and methods of making and using the same |
| 09/14/1999 | US5952232 Expandible microparticle intracellular delivery system |
| 09/14/1999 | US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof |
| 09/14/1999 | US5952226 Hypoxia responsive EPO producing cells |
| 09/14/1999 | US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy |
| 09/14/1999 | US5952223 Compositions for the diagnosis and treatment of Chediak-Higashi syndrome |
| 09/14/1999 | US5952221 A virion having a drug-sensitivity gene and a second gene capable of providing ancillary effects to solid tumor cells; gene therapy and antitumor agents |
| 09/14/1999 | US5952214 Human growth-related CDC10 homolog |
| 09/14/1999 | US5952212 Anticarcinogenic agents and antidiabetic agents |
| 09/14/1999 | US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants |
| 09/14/1999 | US5952197 DNA encoding the chemotactic cytokine III |
| 09/14/1999 | US5952194 Flea nucleic acid sequences and uses thereof |
| 09/14/1999 | US5952193 Adding a protease to an aqueous solution to hydrolyze whey protein, measuring amount of free amino acid of lysine, phenylalanine, leucine and arginine; terminating hydrolysis reaction at predetermined value; treatment of food allergies |
| 09/14/1999 | US5952189 Screening for enzyme inhibitors for antiproliferative agents, antitumor agents, treatment for leukemia, acquired immune deficiency syndrome, nervous system disorders |
| 09/14/1999 | US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952034 Increasing the digestibility of food proteins by thioredoxin reduction |
| 09/14/1999 | US5952011 Human placental transglutaminase polypeptide and nucleotide sequences encoding it, or an allelic variant thereof; use as wound-healing agent |
| 09/14/1999 | US5952009 Administering beta-lactoglobulin wherein at least one lysine of n-terminal amino acid is modified by an aromatic anhydride selected from trimellitic anhydride, 3-hydroxyphthalic anhydride and trimellitic anhydride chloride |
| 09/14/1999 | US5952008 Desolventizing a solution with a pharmaceutically active polypeptide and an adjuvant for enhancing the systemic absorption of the peptide dissolved therein; pulverizing the dry solid, optionally agglomerating, loading into inhaler |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | US5951996 Nonsurgical treatment |
| 09/14/1999 | US5951989 Method for the treatment of dry skin |
| 09/14/1999 | US5951984 Administering immunogen selected from group of protein and peptide to mammel, wherein mammel does not ingest a fat-soluble component substance within 4 hours before and within 2 hours after ingestion of the immunogen |
| 09/14/1999 | US5951983 A light chain framework region derived from a human antibody, a heavy chain framework region derived from a human antibody and light chain cdrs of the non-human monoclonal antibody produced by the cell line deposited as atcc hb11423; |
| 09/14/1999 | US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents |
| 09/14/1999 | US5951980 Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
| 09/14/1999 | US5951979 Mutants (alanine replacing an aspartic acid) lack or have reduced catalytic activity but retain ability to bind substrate resulting in formation of observable and isolatable complex and less immunogenic effects |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | US5951974 At least about 15%, preferably about 30%, of the interferon conjugates have a nonantigenic alkylpolyether attached to a preferential histidine residue; high activity; reacting an n-oxycarbonyloxyimide at acidic ph |
| 09/14/1999 | US5951973 Use of interleukin-4 (IL-4) to treat rheumatoid arthritis |
| 09/14/1999 | US5951971 Eye-drops for treatment of eye disorders and surrounding area comprising cyclosporin and surfactant selected from polyoxyethylene fatty acid esters, polyoxyethylene alkylphenol ether and polyoxyethylene alkyl ethers |
| 09/14/1999 | US5951455 Antisense modulation of G-alpha-11 expression |
| 09/14/1999 | CA2159449C Oesteoblast growth stimulating composition containing pdgf and vitamin d |
| 09/14/1999 | CA2086087C Growth hormone crystals and a process for production of these gh-crystals |
| 09/14/1999 | CA2012732C Production of modified pe40 |
| 09/14/1999 | CA1340748C Synthetic hiv protease gene and method for its expression |
| 09/14/1999 | CA1340747C Hiv-2 virus variants |
| 09/14/1999 | CA1340742C Process for chromatographically separating plasma proteins, protein concentrates produced, particularly factor viii, fibrinogene, von willebrand factor and fibronectin |
| 09/14/1999 | CA1340737C Process for the preparation of pasteurized immunoglobulin preparation |
| 09/13/1999 | CA2226391A1 N-terminal peptides of sdf-1 have functional activities mediated by cxcr4 |
| 09/12/1999 | CA2265209A1 Method of preventing allograft rejection |
| 09/12/1999 | CA2231952A1 Inhibition of tumor growth |
| 09/10/1999 | WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | WO1999045132A1 Poly zinc finger proteins with improved linkers |
| 09/10/1999 | WO1999045128A2 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 09/10/1999 | WO1999045127A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045126A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045121A1 EPITOPE PEPTIDES IMMUNOGENIC AGAINST $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/10/1999 | WO1999045117A2 Interferon, ifn-hy and uses thereof |
| 09/10/1999 | WO1999045116A2 Human homolog of a nuclear migration gene and its use |
| 09/10/1999 | WO1999045115A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | WO1999045113A1 Smad binding elements and uses thereof |
| 09/10/1999 | WO1999045112A2 Chromosome 11-linked coronary heart disease susceptibility gene chd1 |
| 09/10/1999 | WO1999045111A1 Lectomedin materials and methods |
| 09/10/1999 | WO1999045110A1 V-like domain binding molecules |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045107A1 Novel calpain and dna encoding the same |
| 09/10/1999 | WO1999045102A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | WO1999045098A2 Delivery or proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | WO1999045030A1 Human g-protein coupled receptor (gpr25) |
| 09/10/1999 | WO1999045029A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
| 09/10/1999 | WO1999045028A1 Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein |
| 09/10/1999 | WO1999045027A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | WO1999045026A1 Method for increasing the serum half-life of a biologically active molecule |
| 09/10/1999 | WO1999045020A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| 09/10/1999 | WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/10/1999 | WO1999045000A1 Process for producing 4-thiazolylmethyl derivative |
| 09/10/1999 | WO1999044645A1 Compositions and methods of treating tumors |
| 09/10/1999 | WO1999044644A1 Improved eukaryotic expression vector |
| 09/10/1999 | WO1999044642A1 Pharmaceutical compositions and their use |
| 09/10/1999 | WO1999044636A2 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | WO1999044635A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | WO1999044632A1 Treatment of fibromyalgia with low interferon doses |
| 09/10/1999 | WO1999044631A1 Topical composition containing human epidermal growth factor |
| 09/10/1999 | WO1999044630A1 Protein-free preparations |
| 09/10/1999 | WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | WO1999044628A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | WO1999044627A1 Use of hexapeptides for the manufacture of a pharmaceutical composition for the treatment of hot flushes |
| 09/10/1999 | WO1999044625A1 Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation |